Related references
Note: Only part of the references are listed.Stereotactic body radiotherapy for centrally located stage I non-small cell lung cancer
Andrew Bang et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2019)
Synthetic Lethality of PARP Inhibition and Ionizing Radiation is p53-dependent
Steven T. Sizemore et al.
MOLECULAR CANCER RESEARCH (2018)
Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis
Keiichi Jingu et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2018)
An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma
Donna L. Nile et al.
BMC CANCER (2016)
Characterization of in vitro radiosensitization in mammalian cells using biomathematical modelling: implications for hypofractionated radiotherapy with a combined modality approach
Yuji Seo et al.
BRITISH JOURNAL OF RADIOLOGY (2016)
Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair
Xiangjun He et al.
NUCLEIC ACIDS RESEARCH (2016)
Regulation of Single-Strand Annealing and its Role in Genome Maintenance
Ragini Bhargava et al.
TRENDS IN GENETICS (2016)
The role of microhomology in genomic structural variation
Diego Ottaviani et al.
TRENDS IN GENETICS (2014)
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai et al.
CANCER RESEARCH (2012)
Differential effects of poly(ADP-ribose) polymerase inhibition on DNA break repair in human cells are revealed with Epstein-Barr virus
Wenjian Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Response of Human Prostate Cancer Cells and Tumors to Combining PARP Inhibition with Ionizing Radiation
Juan Camilo Barreto-Andrade et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Inhibition of PARP-1 by Olaparib (AZD2281) Increases the Radiosensitivity of a Lung Tumor Xenograft
Joana M. Senra et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Sensitization to Radiation and Alkylating Agents by Inhibitors of Poly(ADP-ribose) Polymerase Is Enhanced in Cells Deficient in DNA Double-Strand Break Repair
Dana A. Loeser et al.
MOLECULAR CANCER THERAPEUTICS (2010)
PARP1 suppresses homologous recombination events in mice in vivo
Alison Claybon et al.
NUCLEIC ACIDS RESEARCH (2010)
Effect of double-strand break DNA sequence on the PARP-1 NHEJ pathway
Marc Audebert et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Inhibition of poly (ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models
Jeffrey M. Albert et al.
CLINICAL CANCER RESEARCH (2007)
PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways
Minli Wang et al.
NUCLEIC ACIDS RESEARCH (2006)
Comparing proportional hazards and accelerated failure time models: an application in influenza
Katie Patel et al.
PHARMACEUTICAL STATISTICS (2006)
Parp-1 protects homologous recombination from interference by Ku and ligase IV in vertebrate cells
H Hochegger et al.
EMBO JOURNAL (2006)
Radiosensitization by the poly(ADP=ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA syntheses
G Noël et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Identification and biochemical characterization of a Werner's syndrome protein complex with Ku70/80 and poly(ADP-ribose) polymerase-1
BM Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining
M Audebert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination
N Schultz et al.
NUCLEIC ACIDS RESEARCH (2003)
Poly(ADP-ribose) polymerase (PARP-1) is not involved in DNA double-strand break recovery -: art. no. 7
G Noël et al.
BMC CELL BIOLOGY (2003)
Share Paper
